Последние исследования


EudraCT Number: 2004-002836-25 Sponsor Protocol Number: QGUY/2004/IL 4-13/01 Start Date: 2004-12-15
Sponsor Name: Aerovance Inc.
Full Title: A Phase IIa Study To Investigate The Effects of AER 001on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration.
Medical condition: Asthma is characterised by an infiltration of the bronchial mucosa with activated T-lymphocytes (T-cells), eosinophils, and to a lessor extent polymorphonuclear leukocytes.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)

EudraCT Number: 2004-000540-24 Sponsor Protocol Number: CLAF237A2310 Start Date: 2004-12-15
Sponsor Name: Novartis Pharma Services AG
Full Title: A multicenter, double-blind, randomized, active controlled study to compare the effect of long term treatment with LAF237 50 mg bid to gliclazide up to 320 mg daily in drug naïve patients with type...
Medical condition: Type II Diabetes
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Completed) IE (Completed) GB (Completed) DE (Completed) IT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-002908-15 Sponsor Protocol Number: B9E-XM-O401 Start Date: 2004-12-15
Sponsor Name: Carlos Gómez Martín
Full Title: ENSAYO FASE I/II, MULTICENTRICO DE LA COMBINACIÓN DE CARBOPLATINO Y GEMCITABINA EN EL TRATAMIENTO DE PACIENTES CON CARCINOMA DE OVARIO EN 1ª RECIDIVA TRAS QUIMIOTERAPIA SENSIBLES A PLATINO
Medical condition: Carcinoma de ovario en primera recidiva tras quimioterapia sensible a platino
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-000089-11 Sponsor Protocol Number: AX-CL-09 Start Date: 2004-12-15
Sponsor Name: Axonyx Inc
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of phenserine-tartrate in patients with probable mild to moderate Alzheimer’s disease
Medical condition: Alzheimer's Disease is caused by a loss of nerve cells in the brain, particularly in the areas associated with memory and learning. The onset of Alzheimer's also affects the levels of a certain neu...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) AT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000333-10 Sponsor Protocol Number: GEN/231/51/BMcK/JCL Start Date: 2004-12-15
Sponsor Name: Research & Innovation Services, University of Dundee
Full Title: The inhibitory effect of local anaesthetics on the G-protein-mediated vascular flare response to bradykinin and substance P
Medical condition: Healthy volunteers
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2004-000304-41 Sponsor Protocol Number: FG-506E-12-03 Start Date: 2004-12-15
Sponsor Name: Astellas Pharma GmbH
Full Title: A MULTICENTRE, 1:1 RANDOMISED, DOUBLE BLIND, TWO ARM PARALLEL GROUP STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF MODIFIED RELEASE TACROLIMUS FK506E (MR4) VERSUS TACROLIMUS FK506 IN COMB...
Medical condition: Patients with end stage kidney disease who will undergo renal transplantation
Disease: Version SOC Term Classification Code Term Level
7.0 10014646 LLT
Population Age: Adults Gender: Male, Female
Trial protocol: CZ (Completed) SE (Completed) HU (Completed) FI (Completed) AT (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-002569-19 Sponsor Protocol Number: Final version Start Date: 2004-12-15
Sponsor Name: Department of Asthma, Allergy and Respiratory Science, GKT School of Medicine, King's College London
Full Title: The effects of systemic vitamin D administration on production of interleukin-10 by peripheral blood T cells in asthmatics and controls.
Medical condition: This trial is being conducted to test the hypothesis that short-term systemic administration of calcitriol in standard therapeutic dosages increases interleukin-10 production by peripheral blood T-...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2004-000669-36 Sponsor Protocol Number: MPR Start Date: 2004-12-15
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Full Title: A MULTICENTER, OPEN LABEL STUDY OF ORAL MELPHALAN, PREDNISONE AND CC-5013 (REVLIMID) (MPR) AS INDUCTION THERAPY IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.
Medical condition: NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.
Disease: Version SOC Term Classification Code Term Level
Population Age: Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-001644-80 Sponsor Protocol Number: FG-506-06-41 Start Date: 2004-12-15
Sponsor Name: Fujisawa GmbH
Full Title: Clinical study on tacrolimus ointment over the long-term “Control Study - Children” Revised version of FG-506-06-39
Medical condition: Atopic Dermatitis
Disease: Version SOC Term Classification Code Term Level
7.0 10003639 LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: HU (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-002700-16 Sponsor Protocol Number: R096769-PRE-3001 Start Date: 2004-12-14
Sponsor Name: Janssen-Cilag International N.V.
Full Title: A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Subjects With Premature Ejaculation
Medical condition: Premature Ejaculation (PE)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male
Trial protocol: CZ (Completed) FI (Completed) HU (Completed) GB (Completed) SE (Completed) DE (Completed) AT (Completed) ES (Completed) IT (Prematurely Ended)
Trial results: View results
Подписаться